3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow Conjunctivitis, Bacterial: new trials by email Literature Review of Conjunctivitis, Bacterial trials Research Report on Conjunctivitis, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. Pazufloxacin, Zymar - Conjunctivitis, Bacterial | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 46 | 2018-10-01 | 2021-08-24 |
| Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis Besifloxacin, Vehicle - Bacterial Conjunctivitis | Phase 3 | Terminated | Bausch & Lomb Incorporated | 136 | 2013-02-01 | 2014-10-01 |
| Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis Besivance, Gatifloxacin - Bacterial Conjunctivitis | Phase 3 | Terminated | Bausch & Lomb Incorporated | 33 | 2011-05-01 | 2014-09-03 |
Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Conjunctival Diseases (3) · Conjunctivitis (3) · Eye Diseases (3) · Eye Infections (3) · Infections (3) · Eye Infections, Bacterial (2)
Gatifloxacin (2) · besifloxacin (2) · pazufloxacin (1)
Bausch & Lomb Incorporated (2) · Laboratorios Sophia S.A de C.V. (1)
United States (2) · Mexico (1)